The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has ...

This isn’t just about patients getting ill. A vaccine could also help prevent healthcare staff absences, with current NHS ...